KPTI
Price
$3.85
Change
-$0.22 (-5.41%)
Updated
Jul 18 closing price
Capitalization
33.26M
LRMR
Price
$3.21
Change
-$0.11 (-3.31%)
Updated
Jul 18 closing price
Capitalization
205.53M
17 days until earnings call
Interact to see
Advertisement

KPTI vs LRMR

Header iconKPTI vs LRMR Comparison
Open Charts KPTI vs LRMRBanner chart's image
Karyopharm Therapeutics
Price$3.85
Change-$0.22 (-5.41%)
Volume$151.97K
Capitalization33.26M
Larimar Therapeutics
Price$3.21
Change-$0.11 (-3.31%)
Volume$480.4K
Capitalization205.53M
KPTI vs LRMR Comparison Chart in %
Loading...
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KPTI vs. LRMR commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KPTI is a Hold and LRMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (KPTI: $3.85 vs. LRMR: $3.21)
Brand notoriety: KPTI and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KPTI: 128% vs. LRMR: 44%
Market capitalization -- KPTI: $33.26M vs. LRMR: $205.53M
KPTI [@Biotechnology] is valued at $33.26M. LRMR’s [@Biotechnology] market capitalization is $205.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KPTI’s FA Score shows that 1 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • KPTI’s FA Score: 1 green, 4 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than KPTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KPTI’s TA Score shows that 3 TA indicator(s) are bullish while LRMR’s TA Score has 3 bullish TA indicator(s).

  • KPTI’s TA Score: 3 bullish, 5 bearish.
  • LRMR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than KPTI.

Price Growth

KPTI (@Biotechnology) experienced а -15.38% price change this week, while LRMR (@Biotechnology) price change was -5.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

LRMR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($206M) has a higher market cap than KPTI($33.3M). LRMR YTD gains are higher at: -17.054 vs. KPTI (-62.048). KPTI has higher annual earnings (EBITDA): -19.64M vs. LRMR (-105.02M). LRMR has more cash in the bank: 158M vs. KPTI (69.9M). LRMR has less debt than KPTI: LRMR (4.87M) vs KPTI (187M). KPTI has higher revenues than LRMR: KPTI (142M) vs LRMR (0).
KPTILRMRKPTI / LRMR
Capitalization33.3M206M16%
EBITDA-19.64M-105.02M19%
Gain YTD-62.048-17.054364%
P/E RatioN/AN/A-
Revenue142M0-
Total Cash69.9M158M44%
Total Debt187M4.87M3,843%
FUNDAMENTALS RATINGS
KPTI vs LRMR: Fundamental Ratings
KPTI
LRMR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9344
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPTI's Valuation (5) in the Biotechnology industry is in the same range as LRMR (22) in the null industry. This means that KPTI’s stock grew similarly to LRMR’s over the last 12 months.

KPTI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that KPTI’s stock grew similarly to LRMR’s over the last 12 months.

KPTI's SMR Rating (100) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that KPTI’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (44) in the null industry is somewhat better than the same rating for KPTI (93) in the Biotechnology industry. This means that LRMR’s stock grew somewhat faster than KPTI’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as KPTI (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to KPTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KPTILRMR
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 25 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
KPTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INVZ1.890.19
+11.18%
Innoviz Technologies Ltd
COOP150.432.23
+1.50%
Mr Cooper Group
KOP32.340.08
+0.25%
Koppers Holdings
BDX180.90N/A
N/A
Becton Dickinson and Co
CAMP1.59-0.07
-4.22%
Camp4 Therapeutics Corp

KPTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with MGNX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPTI
1D Price
Change %
KPTI100%
-5.41%
MGNX - KPTI
38%
Loosely correlated
N/A
XNCR - KPTI
36%
Loosely correlated
-1.10%
LRMR - KPTI
36%
Loosely correlated
-3.31%
XENE - KPTI
36%
Loosely correlated
N/A
NTLA - KPTI
36%
Loosely correlated
+1.94%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-3.31%
ERAS - LRMR
51%
Loosely correlated
+0.67%
ACLX - LRMR
50%
Loosely correlated
-4.74%
OCUL - LRMR
49%
Loosely correlated
-0.44%
SYRE - LRMR
49%
Loosely correlated
-3.55%
ALEC - LRMR
49%
Loosely correlated
-4.79%
More